- Home
- AGEN vs PSQH Comparison
AGEN vs PSQH Comparison
Compare AGEN & PSQH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGEN
- PSQH
- Stock Information
- Founded
- AGEN 1994
- PSQH 2021
- Country
- AGEN United States
- PSQH United States
- Employees
- AGEN N/A
- PSQH N/A
- Industry
- AGEN Biotechnology: Biological Products (No Diagnostic Substances)
- PSQH Advertising
- Sector
- AGEN Health Care
- PSQH Consumer Discretionary
- Exchange
- AGEN Nasdaq
- PSQH Nasdaq
- Market Cap
- AGEN 87.7M
- PSQH 89.7M
- IPO Year
- AGEN 2000
- PSQH N/A
- Fundamental
- Price
- AGEN $4.28
- PSQH $1.68
- Analyst Decision
- AGEN Buy
- PSQH Strong Buy
- Analyst Count
- AGEN 2
- PSQH 2
- Target Price
- AGEN $14.50
- PSQH $6.00
- AVG Volume (30 Days)
- AGEN 497.3K
- PSQH 1.2M
- Earning Date
- AGEN 08-11-2025
- PSQH 08-12-2025
- Dividend Yield
- AGEN N/A
- PSQH N/A
- EPS Growth
- AGEN N/A
- PSQH N/A
- EPS
- AGEN N/A
- PSQH N/A
- Revenue
- AGEN $101,706,000.00
- PSQH $27,580,806.00
- Revenue This Year
- AGEN $26.25
- PSQH $67.78
- Revenue Next Year
- AGEN N/A
- PSQH $78.76
- P/E Ratio
- AGEN N/A
- PSQH N/A
- Revenue Growth
- AGEN N/A
- PSQH 93.83
- 52 Week Low
- AGEN $1.38
- PSQH $1.55
- 52 Week High
- AGEN $7.34
- PSQH $7.77
- Technical
- Relative Strength Index (RSI)
- AGEN 38.46
- PSQH 41.81
- Support Level
- AGEN $4.31
- PSQH $1.66
- Resistance Level
- AGEN $4.70
- PSQH $1.77
- Average True Range (ATR)
- AGEN 0.26
- PSQH 0.17
- MACD
- AGEN -0.01
- PSQH -0.01
- Stochastic Oscillator
- AGEN 17.86
- PSQH 19.53
About AGEN Agenus Inc.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
About PSQH PSQ Holdings Inc.
PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.